fda warning glp-1 october 2025 May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations – Partnership for Safe Medicines FDA warns against compounded GLP-1

When travelling within the UK or departing from UK airports, you should carry your medication in its original packaging with the pharmacy label clearly visible, showing your name, the medication name, dosage, and prescribing details

This whole-body approach to your wellness enables our team to support your changing needs as you regain inner balance

Stay Sharp

PlexusDx helps patients understand their genetic predispositions in peptide signaling pathways and discuss these insights with their healthcare provider to select a medication formulation and dosing strategy aligned with their personal tolerability profile